Stoke Therapeutics, Inc. (STOK) › Net IncomeStoke Therapeutics, Inc. (STOK) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$12.52M2019: -$32.33M2020: -$52.24M2021: -$85.81M2022: -$101.07M2023: -$104.70M2024: -$88.98M2025: -$6.88M-$6.88M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$6.88M+92.3%2024-$88.98M+15.0%2023-$104.70M-3.6%2022-$101.07M-17.8%2021-$85.81M-64.2%2020-$52.24M-61.6%2019-$32.33M-158.2%2018-$12.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share